On May 10, trials of the Russian vaccine Sputnik V will begin by a joint group of experts from Coreper and the World Health Organization, AMPE reports.
A WHO spokesman told Reuters in response to his inquiry: “Good manufacturing practice audits will be conducted from May 10 to the first week of June.” When asked about the data obtained from clinical trials, the answer was: “We are still receiving information from the manufacturer.”
Currently, a team of WHO and Coreper specialists is monitoring the correctness of the clinical practice of the vaccine, which was developed by Russian scientists from the Gamaleya Institute. The next round of Sputnik V trials will begin in May, with the participation of representatives from the European Medicines Agency.
Sergei Vershinin, Russia’s Deputy Minister of Health, on Tuesday met with Adan Gebregesus, Director General of the World Health Organization. Following the talks, Gebregesus tweeted: “WHO appreciates Russia’s efforts to comply with the conditions for use in emergencies.”
Sputnik V has already been approved by more than 50 countries around the world. EU member states can now on my own make a decision on its acquisition. Greece admits a certificate of vaccination with the Russian vaccine, which will make it easier for tourists from Russia to travel and summer vacations in the country. During a visit to Moscow, Greece’s tourism minister, Haris Theocharis, assured that the Greek national vaccination committee wants to include the Russian vaccine, as the equivalent of the European one, for travel.